GlassScriptPhysician profile
Mohanad Eltahir
NPI 1649634320
$23,589.00
in general payments reported to CMS, 2019-2025
31 companies · $8,648 in 2025
The $8,648 reported for 2025 was more than what 95% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,321 · 2020: $170 · 2021: $2,061 · 2022: $4,279 · 2023: $2,769 · 2024: $1,341 · 2025: $8,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,891 · Food and Beverage: $4,867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,891.03 |
| Food and Beverage | $4,867.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,441.71 | 2019-2025 | Hoffmann, Ortholoc 3di, Allofiber |
| Smith+Nephew, INC. | $3,911.26 | 2019-2025 | Pico, Collagenase Santyl, Versajet |
| Treace Medical Concepts, INC. | $3,455.84 | 2023-2025 | |
| Vilex LLC | $2,753.09 | 2022 | |
| Paragon 28, INC. | $2,729.00 | 2024-2025 | Apex 3d, Monkey Rings, Portfolio |
| Wright Medical Technology, INC. | $1,436.49 | 2019 | |
| Arteriocyte Medical Systems, INC. | $1,035.25 | 2019-2024 | Magellan |
| Acumed LLC | $623.00 | 2021 | |
| Organogenesis INC. | $438.00 | 2019-2025 | Cygnus Dual, Puraply |
| Kerecis Limited | $432.18 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $317.64 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Musculoskeletal Transplant Foundation INC. | $213.80 | 2023 | |
| Innovation Technologies INC | $120.78 | 2024 | Irrisept |
| Anika Therapeutics, INC. | $80.87 | 2021 | |
| Axogen | $78.72 | 2023 | Avance Nerve Graft |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $75.55 | 2024 | Truelok |
| Medline Industries LP | $47.12 | 2023 | |
| Lifenet Health | $44.63 | 2025 | Theragenesis Wound Matrix |
| Advanced Oxygen Therapy INC. | $36.40 | 2022-2025 | Topical Oxygen Chamber For Extremities |
| Paratek Pharmaceuticals, INC. | $36.00 | 2019-2022 | |
| Amniox Medical, INC. | $35.95 | 2019 | |
| Averitas Pharma INC. | $35.55 | 2024 | Qutenza |
| Kci USA, INC. | $35.33 | 2019-2020 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $28.60 | 2019-2020 | |
| Misonix INC | $28.31 | 2020-2021 | |
| Grt US Holding, INC. | $26.27 | 2021 | |
| Abbvie INC. | $25.50 | 2021 | |
| Globus Medical, INC. | $20.84 | 2025 | Senza |
| Surgenex LLC | $19.64 | 2025 | Pellograft, Ardeograft, Surgraft |
| Solventum Corporation | $18.73 | 2025 | V.A.C. Veraflo Cleanse Choice, V.A.C. Dermatac, Prevena |
| Ets Wound Care LLC | $6.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohanad Eltahir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.